Our Entrepreneurs

Christopher Whitfield

Batswadi Pharmaceuticals

Christopher Whitfield Christopher Whitfield
“I saw an opportunity to transform the pharmaceutical industry in South Africa.”
Country
South Africa
Industry
Healthcare
Year selected
2007
Website

Company Snapshot

Christopher founded Batswadi Pharmaceuticals in October 2005 as a specialist healthcare company focusing on four core business areas: pharmaceuticals, diagnostics, research and development, and consumer health. After jump-starting the company by leading a management buy-out of Eli Lilly’s insulin portfolio in South Africa, Christopher has quickly built Batswadi into a diversified company with significant potential. As the only black-empowered (majority-owned by historically disadvantaged South Africans) pharmaceutical company in South Africa, Batswadi is a rising star.

Endeavor and Batswadi Pharmaceuticals

Christopher is actively receiving guidance in the areas of fundraising and branding. In addition to local support, he has benefited from the Global eMBA and G-Lab programs, and an Immersion Tour.

Christopher has been on the Endeavor South Africa board since 2008, and serves as a local panelist.

From the Entrepreneurship Blog

Events

Endeavor Indonesia Celebrates the Power of High-Impact Entrepreneurship with Scale-Up 2.0 Conference

February 25th, 2015 — by admin

Endeavor Indonesia hosted a Scale-Up 2.0 Conference on Tuesday, February 3rd that brought together entrepreneurs and industry experts for a day-long event to address challenges to the region's entrepr…

Read more

In the news

Argentina's Jampp, A Mobile App Marketing Platform, Raises Funding with Participation from Endeavor Catalyst

February 24th, 2015 — by admin

Argentina's Jampp, a platform that helps mobile app advertisers acquire and engage users, has raised $7 million in a Series A round led by Highland Europe. The round of funding also included parti…

Read more

Contact us

Press center

Community

Newsletter Sign Up